Vor Biopharma stock rating upgraded to Buy by H.C. Wainwright on telitacicept deal

Related
Smaller offices, private spaces, more snacks: Here’s how com...
5 minutes ago
0
Constellation Brands gains after Jefferies recommended buyin...
6 minutes ago
0
Carrier is latest global firm to file suit against India ove...
7 minutes ago
0
Blackstone to pay $200M for Allegiant resort - report
9 minutes ago
0
Strategy makes no bitcoin purchases last week
11 minutes ago
0
PesoRama announces upsizing of offering to $6.8M
15 minutes ago
0
Moog acquires COTSWORKS for $63 million in cash and stock de...
17 minutes ago
0
Needham highlights customer, partner check on Zscaler's Z-Fl...
21 minutes ago
0
LQWD acquires additional bitcoin increasing holdings to ~181...
24 minutes ago
0
POET Technologies announces $25 million offering
32 minutes ago
0
U.S. companies including Exxon, Chevron to sign $34B Indones...
35 minutes ago
0
Trump says higher tariffs set to kick in on Aug. 1
40 minutes ago
0
Unisync announces retirement of Douglas Good as CEO
40 minutes ago
0
BitFuFu produces 445 BTC in June
42 minutes ago
0
Altura Energy appoints Ashley Lastinger as CEO
46 minutes ago
0
Collegium announces $150M share repurchase program
48 minutes ago
0
Vermont dairy farm migrant ICE raids put industry on edge: ‘...
49 minutes ago
0
DeFi Technologies' Valour reports $771 million in AUM
50 minutes ago
0
Mogo repurchases 2% of outstanding shares in Q2
51 minutes ago
0
CrowdStrike dips after rating cut at Piper Sandler
51 minutes ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved